Sanofi’s Commitment to Hematology

Make Your Pledge4Rare this Rare Disease Day

Sanofi's 2019 Highlights

Best wishes for 2020 <br>from all of us at Sanofi

5 things you need to know - Risk of heart Disease

KiDS Program Aims to Keep Children with Diabetes in School

Science and Innovation Image

Sanofi Scientists Aim to Stop Abnormal Immune Response in Rare Blood Disorders

Real-World Evidence Turns Experience into Knowledge

Next Generation Approaches to Pioneer Breakthrough Therapies

  • Camera
    Press releases
    2020-01-20MMMM DD YYYY
    Sanofi : Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Synthorx

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies